Compendium of the most significant studies with reference to properties, intake, effects.

Alsalhi, W., Alalola, A., Randolph, M., Gwillim, E., & Tosti, A. (2020). Novel drug delivery approaches for the management of hair loss. Expert opinion on drug delivery, 17(3), 287-295.

Abstract. Alopecia is a common clinical complaint for patients and often a source of significant psychological distress. The goal of therapy is to stop hair loss and encourage regrowth. Many treatment modalities are available and novel drug delivery approaches are needed to maximize results and minimize potential side effects… myristoyl pentapeptide-17, adenosine, piroctone olamine, retinol, and caffeine, significantly...

reduced hair shedding,

Sachdev, M., Velugotla, K., Revanker, S., & Somasekhar, G. (2020). An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum. The Journal of Clinical and Aesthetic Dermatology, 13(2), 61.

Abstract. We sought to evaluate the efficacy of a polygrowth factor serum for increasing length, luster, thickness, and volume of eyelashes in a group of healthy Indian women. 

Iriarte, C., Awosika, O., Rengifo-Pardo, M., & Ehrlich, A. (2017). Review of applications of microneedling in dermatology. Clinical, cosmetic and investigational dermatology, 10, 289.

Abstract. Microneedling (MN) is a novel therapeutic modality in dermatology. Through physical trauma from needle penetration, MN induces a wound healing cascade with minimal damage to the epidermis. This allows for enhancement in the absorption of mainstay topical therapies across the thick stratum corneum. MN has become increasingly utilized over the last several years as it is a relatively simple procedure that is cost-effective, well tolerated, and offers both cosmetic and therapeutic benefits.